Search results for " Research Design"

showing 10 items of 95 documents

Nuovo realismo e metodi di ricerca misti

2014

Il nuovo realismo ha evidenziato i limiti del costruttivismo sociale e del cosiddetto «pensiero debole», che rischia di sfociare nel nichilismo. Sono stati recentemente rimossi dei pregiudizi che impedivano di cogliere la realtà dei fatti educativi nella sua concreta evidenza. Tuttavia un’apertura alla prospettiva metafisica offrirebbe al nuovo realismo ulteriori spazi epistemologici. In tale senso il contributo del realismo critico potrebbe aiutare a superare l’artificiosa antinomia tra il ruolo attivo del soggetto conoscente e la rilevazione oggettiva dei fatti educativi. Se si realizzasse questa apertura la conoscenza scientifica e la conoscenza corrente non sarebbero più viste come anti…

NihilismSociology of scientific knowledgeSocial PsychologyMetaphysicscritical realism experimental method qualitative approach quantitative approach research designs disegni di ricerca realismo critico approccio qualitativo approccio quantitativo metodo sperimentaleSettore M-PED/04 - Pedagogia SperimentaleEducationEpistemologyCritical Realism Experimental Method Qualitative Approach Quantitative Approach Research DesignsAntinomyDisegni di ricerca Realismo critico Approccio qualitativo Approccio quantitativo Metodo sperimentaleCritical realism (philosophy of perception)Developmental and Educational PsychologyNew realismSociologyExperimental methodslcsh:LSocial constructivismlcsh:EducationJournal of Educational, Cultural and Psychological Studies
researchProduct

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists

2010

Abstract Background Overall survival (OS) is the gold standard for the demonstration of a clinical benefit in cancer trials. Replacement of OS by a surrogate endpoint allows to reduce trial duration. To date, few surrogate endpoints have been validated in digestive oncology. The aim of this study was to draw up an ordered list of potential surrogate endpoints for OS in digestive cancer trials, by way of a survey among clinicians and methodologists. Secondary objective was to obtain their opinion on surrogacy and quality of life (QoL). Methods In 2007 and 2008, self administered sequential questionnaires were sent to a panel of French clinicians and methodologists involved in the conduct of …

OncologyCancer ResearchTime FactorsDigestive System Neoplasms[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineQuality of lifeSurveys and QuestionnairesMedicine030212 general & internal medicineMESH: Treatment OutcomeResponse rate (survey)MESH : Evidence-Based MedicineClinical Trials as TopicEvidence-Based MedicineMESH: Endpoint DeterminationMESH: Research DesignMESH : QuestionnairesMESH : Research Designlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens3. Good healthMESH: Reproducibility of Resultsmedicine.anatomical_structureTreatment OutcomeOncologyResearch Design030220 oncology & carcinogenesisData Interpretation StatisticalMESH: Survival AnalysisMESH : Disease-Free SurvivalMESH : Endpoint DeterminationFranceMESH : Time FactorsResearch Articlemedicine.medical_specialtyMESH: Clinical Trials as TopicEndpoint DeterminationRectum[SDV.CAN]Life Sciences [q-bio]/CancerMESH : Treatment Outcomelcsh:RC254-282Disease-Free Survival03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerInternal medicineGeneticsHumansMESH : Data Interpretation StatisticalMESH : FranceSurvival analysisMESH: Humansbusiness.industrySurrogate endpointMESH: Digestive System NeoplasmsMESH : Reproducibility of ResultsMESH: QuestionnairesMESH : HumansMESH: Time FactorsCancerReproducibility of ResultsMESH: Quality of LifeMESH : Quality of Lifemedicine.diseaseSurvival AnalysisMESH : Clinical Trials as TopicMESH: FranceLocalized diseaseEndpoint DeterminationMESH: Disease-Free SurvivalQuality of LifeMESH : Digestive System NeoplasmsMESH : Survival AnalysisbusinessMESH: Data Interpretation StatisticalMESH: Evidence-Based MedicineBMC Cancer
researchProduct

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.

2013

BackgroundBone metastasis represents an increasing clinical problem in advanced renal cell carcinoma (RCC) as disease-related survival improves. There are few data on the natural history of bone disease in RCC.Patients and methodsData on clinicopathology, survival, skeletal-related events (SREs), and bone-directed therapies for 398 deceased RCC patients (286 male, 112 female) with evidence of bone metastasis were statistically analyzed.ResultsMedian time to bone metastasis was 25 months for patients without bone metastasis at diagnosis. Median time to diagnosis of bone metastasis by MSKCC risk was 24 months for good, 5 months for intermediate, and 0 months for poor risk. Median number of SR…

OncologyMaleAnatomy and PhysiologyBone diseaseEpidemiologySettore MED/06 - Oncologia Medicamedicine.medical_treatmentMetastasisMetastasisbone metastasesRenal cell carcinomaBasic Cancer ResearchMedicineMusculoskeletal SystemMultidisciplinaryDiphosphonatesrenal cell carcinoma bone metastasis zoledronic acidQRBone metastasisKidney NeoplasmsOncologyItalyObservational StudiesDisease ProgressionMedicineFemaleCancer Epidemiologymedicine.drugResearch Articlemedicine.medical_specialtyClinical Research DesignSciencerenal cancerBone NeoplasmsInternal medicineHumansBonerenal cancer; bone metastasesRetrospective Studiesbusiness.industryRenal Cell CarcinomaCancerCancers and NeoplasmsBone fracturemedicine.diseaseSurgeryRadiation therapyGenitourinary Tract TumorsZoledronic acidbusiness
researchProduct

Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis

2014

Driven by genomic somatic variation, tumour tissues are typically heterogeneous, yet unbiased quantitative methods are rarely used to analyse heterogeneity at the protein level. Motivated by this problem, we developed automated image segmentation of images of multiple biomarkers in Ewing sarcoma to generate distributions of biomarkers between and within tumour cells. We further integrate high dimensional data with patient clinical outcomes utilising random survival forest (RSF) machine learning. Using material from cohorts of genetically diagnosed Ewing sarcoma with EWSR1 chromosomal translocations, confocal images of tissue microarrays were segmented with level sets and watershed algorithm…

PathologyCytoplasmMicroarrayslcsh:MedicineCohort StudiesMedicine and Health Scienceslcsh:ScienceMultidisciplinaryTissue microarrayApplied MathematicsPrognosisRandom forestBioassays and Physiological AnalysisOncologyFeature (computer vision)Research DesignPhysical SciencesBiomarker (medicine)SarcomaAnatomyAlgorithmsStatistics (Mathematics)Research Articlemedicine.medical_specialtyComputer and Information SciencesHistologyClinical Research DesignCD99Feature selectionBone NeoplasmsComputational biologySarcoma EwingBiology12E7 AntigenResearch and Analysis MethodsAntigens CDArtificial IntelligenceCell Line TumormedicineCancer Detection and DiagnosisBiomarkers TumorHumansStatistical MethodsCell Nucleuslcsh:RBiology and Life SciencesComputational BiologyImage segmentationmedicine.diseaselcsh:QCell Adhesion MoleculesMathematicsPLoS ONE
researchProduct

Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach

2013

Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected b…

PathologyMouseTumor PhysiologyCancer Treatmentlcsh:MedicineMiceBasic Cancer ResearchMedicineUltrasonicslcsh:ScienceBladder Cancer and Urothelial Neoplasias of the Urinary TractMultidisciplinaryUltrasoundAnimal ModelsBladder CancerOncolytic VirusesOncologySurgery Computer-AssistedMedicineOncology AgentsFemaleImmunotherapyResearch Articlemedicine.drugmedicine.medical_specialtyClinical Research DesignUrologyTransplantation HeterologousModel OrganismsIn vivoCell Line TumorAnimalsHumansBioluminescence imagingddc:610Animal Models of DiseaseBiologyCell ProliferationCisplatinBladder cancerbusiness.industrylcsh:RCancers and NeoplasmsChemotherapy and Drug Treatmentmedicine.diseaseGemcitabineOncolytic virusTransplantationGenitourinary Tract TumorsUrinary Bladder NeoplasmsFeasibility Studieslcsh:QbusinessPLoS ONE
researchProduct

Usual Care and Informed Consent in Clinical Trials of Oxygen Management in Extremely Premature Infants

2016

Objective The adequacy of informed consent in the Surfactant, Positive Pressure, and Pulse Oximetry Randomized Trial (SUPPORT) has been questioned. SUPPORT investigators and publishing editors, heads of government study funding agencies, and many ethicists have argued that informed consent was adequate because the two oxygen saturation target ranges studied fell within a range commonly recommended in guidelines. We sought to determine whether each oxygen target as studied in SUPPORT and four similar randomized controlled trials (RCTs) was consistent with usual care. Design/Participants/Setting PubMed, EMBASE, Web of Science, and Scopus were searched for English articles back to 1990 providi…

PediatricsComparative Effectiveness ResearchAlternative medicinePsychological interventionlcsh:MedicineNeonatal Carelaw.inventionDatabase and Informatics Methods0302 clinical medicineRandomized controlled triallawInformed consentMedicine and Health Sciences030212 general & internal medicineOximetryDatabase Searchinglcsh:ScienceRandomized Controlled Trials as TopicMultidisciplinarymedicine.diagnostic_testHospitalsInformed Consent By MinorsChemistryIntensive Care UnitsResearch DesignInfant Extremely PrematurePhysical SciencesResearch ArticleChemical ElementsAdultmedicine.medical_specialtyDrug Research and DevelopmentClinical Research DesignDeath RatesComparative effectiveness researchResearch and Analysis Methods03 medical and health sciencesPopulation Metrics030225 pediatricsmedicineHumansClinical TrialsIntensive care medicineOxygen saturationDemographyPharmacologyPopulation Biologybusiness.industrylcsh:RInfant NewbornBiology and Life SciencesRandomized Controlled TrialsClinical trialOxygenHealth CarePulse oximetryHealth Care FacilitiesPeople and PlacesIntensive Care Neonatallcsh:QClinical MedicinebusinessPLoS ONE
researchProduct

Total plasma protein in very preterm babies: prognostic value and comparison with illness severity scores

2013

International audience; OBJECTIVE: We aimed to investigate the predictive value for severe adverse outcome of plasma protein measurements on day one of life in very preterm infants and to compare total plasma protein levels with the validated illness severity scores CRIB, CRIB-II, SNAP-II and SNAPPE-II, regarding their predictive ability for severe adverse outcome. METHODS: We analyzed a cohort of infants born at 24-31 weeks gestation, admitted to the tertiary intensive care unit of a university hospital over 10.5 years. The outcome measure was "severe adverse outcome" defined as death before discharge or severe neurological injury on cranial ultrasound. The adjusted odd ratio (aOR) and 95%…

PediatricsMultivariate analysisCritical Care and Emergency MedicineEpidemiology[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/Pediatricslcsh:MedicinePediatricslaw.inventionCohort Studies0302 clinical medicinelawInfant Very Low Birth Weight030212 general & internal medicineProspective StudiesPediatric Epidemiologylcsh:ScienceMultidisciplinaryArea under the curveBlood ProteinsIntensive care unit3. Good healthCohortMedicineInfant PrematureResearch Articlemedicine.medical_specialtyPediatric Critical CareClinical Research DesignBirth weightFluid Management03 medical and health sciencesHypoproteinemia030225 pediatricsInternal medicinemedicineHumansPrematureRetrospective StudiesNutrition[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsReceiver operating characteristicbusiness.industryVery Low Birth Weightlcsh:RInfant NewbornInfantmedicine.diseaseNewbornConfidence intervallcsh:QNeonatologybusiness
researchProduct

Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protoc…

2018

Postoperative pulmonary complications (PPC) may result in longer duration of in-hospital stay and even mortality. Both thoracic surgery and intraoperative mechanical ventilation settings add considerably to the risk of PPC. It is unclear if one-lung ventilation (OLV) for thoracic surgery with a strategy of intraoperative high positive end-expiratory pressure (PEEP) and recruitment maneuvers (RM) reduces PPC, compared to low PEEP without RM.PROTHOR is an international, multicenter, randomized, controlled, assessor-blinded, two-arm trial initiated by investigators of the PROtective VEntilation NETwork. In total, 2378 patients will be randomly assigned to one of two different intraoperative me…

Positive-Pressure RespirationMechanical ventilation; one-lung ventilation; positive end-expiratory pressure; postoperative pulmonary complication; recruitment maneuver; thoracic surgery; Humans; Intraoperative Complications; One-Lung Ventilation; Positive-Pressure Respiration; Research Design; Sample Size; Thoracic Surgical Procedures; Randomized Controlled Trials as TopicResearch DesignSample SizeHumansCorrectionThoracic Surgical ProceduresIntraoperative ComplicationsOne-Lung VentilationRandomized Controlled Trials as TopicTrials
researchProduct

Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view.

2014

Randomized Controlled Trials (RCTs) are the "gold standard" for evaluating treatment outcomes providing information on treatments "efficacy". They are designed to test a therapeutic hypothesis under optimal setting in the absence of confounding factors. For this reason they have high internal validity. The strict and controlled conditions in which they are conducted, leads to low generalizability because they are performed in conditions very different from real life usual care. Conversely, real life studies inform on the "effectiveness" of a treatment, that is, the measure of the extent to which an intervention does what is intended to do in routine circumstances. At variance to RCTs, real …

Pulmonary and Respiratory MedicineChronic Obstructivemedicine.medical_specialtyAsthma; COPD; Randomized controlled trials; Real life studies; Asthma; Confounding Factors (Epidemiology); Humans; Pulmonary Disease Chronic Obstructive; Randomized Controlled Trials as Topic; Research Design; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)Alternative medicineSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionPulmonary DiseasePulmonary Disease Chronic ObstructiveRandomized controlled triallawIntervention (counseling)medicineCOPDHumansPharmacology (medical)Generalizability theoryMedical physicsInternal validityReal life studiesRandomized Controlled Trials as Topicbusiness.industryBiochemistry (medical)Gold standardConfounding Factors EpidemiologicVariance (accounting)Confounding Factors (Epidemiology)AsthmaReal life studieRandomized controlled trials; Real life studies; Asthma; COPDRandomized controlled trialResearch DesignRandomized controlled trialsPhysical therapybusinessStrengths and weaknesses
researchProduct

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

2016

Background: Shortening duration of peginterferon-based HCV treatment reduces associated burden for patients. Primary objectives of this study were to assess the efficacy against the minimally acceptable response rate 12 weeks post-treatment (SVR12) and safety of simeprevir plus PR in treatment-naïve HCV GT1 patients treated for 12 weeks. Additional objectives included the investigation of potential associations of rapid viral response and baseline factors with SVR12. Methods: In this Phase III, open-label study in treatment-naïve HCV GT1 patients with F0-F2 fibrosis, patients with HCV-RNA 12-week regimen. Conclusions: Overall SVR12 rate (66%) was below the target of 80%, indicating that sho…

RNA virusesMale0301 basic medicineSimeprevirDecision AnalysisPsychologie appliquéelcsh:MedicineHepacivirusmedicine.disease_causeTherapy naivechemistry.chemical_compoundMathematical and Statistical Techniques0302 clinical medicineRecurrenceSimeprevirlcsh:SciencePathology and laboratory medicineMultidisciplinaryHepatitis C virusPharmaceuticsHepatitis CMedical microbiologyViral LoadMiddle AgedSciences bio-médicales et agricolesPEGINTERFERON/RIBAVIRINHepatitis C3. Good healthTreatment OutcomeResearch DesignVirusesPhysical SciencesRegression AnalysisEngineering and TechnologyFemale030211 gastroenterology & hepatologyPathogensManagement EngineeringBiologieViral loadStatistics (Mathematics)HumanResearch ArticleAdultmedicine.medical_specialtyGenotypeClinical Research DesignHepatitis C virusResearch and Analysis MethodsMicrobiologyAntiviral AgentsYoung Adult03 medical and health sciencesDrug TherapyVirologyRibavirinmedicineHumansddc:610Statistical MethodsAgedAntiviral AgentMedicine and health sciencesHepaciviruFlavivirusesbusiness.industryRibavirinDecision Treeslcsh:ROrganismsViral pathogensBiology and Life Sciencesmedicine.diseaseFibrosisVirologyHepatitis virusesMicrobial pathogensClinical trial030104 developmental biologychemistryFamily medicineMultivariate Analysislcsh:QAdverse EventsbusinessMathematicsViral Transmission and InfectionDevelopmental BiologyPLOS ONE
researchProduct